These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 24198480)

  • 21. Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications.
    Ni D; Jiang D; Ehlerding EB; Huang P; Cai W
    Acc Chem Res; 2018 Mar; 51(3):778-788. PubMed ID: 29489335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategic targeting of non-small-cell lung cancer utilizing genetic material-based delivery platforms of nanotechnology.
    Chaudhary S; Singh A; Kumar P; Kaushik M
    J Biochem Mol Toxicol; 2021 Jul; 35(7):e22784. PubMed ID: 33826765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, in vitro and in vivo evaluation of radiolabeled nanoparticles.
    Shokeen M; Fettig NM; Rossin R
    Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):267-77. PubMed ID: 18475250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanotechnology-based radiation therapy to cure cancer and the challenges in its clinical applications.
    Arif M; Nawaz AF; Ullah Khan S; Mueen H; Rashid F; Hemeg HA; Rauf A
    Heliyon; 2023 Jun; 9(6):e17252. PubMed ID: 37389057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments.
    Dawidczyk CM; Russell LM; Searson PC
    Front Chem; 2014; 2():69. PubMed ID: 25202689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reinvention of chemotherapy: drug conjugates and nanoparticles.
    Nguyen-Ngoc T; Raymond E
    Curr Opin Oncol; 2015 May; 27(3):232-42. PubMed ID: 25783982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in Nanoparticles as Anticancer Drug Delivery Vector: Need of this Century.
    Ali I; Mukhtar SD; Ali HS; Scotti MT; Scotti L
    Curr Pharm Des; 2020; 26(15):1637-1649. PubMed ID: 32013826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Redox Potential and ROS-Mediated Nanomedicines for Improving Cancer Therapy.
    Glass SB; Gonzalez-Fajardo L; Beringhs AO; Lu X
    Antioxid Redox Signal; 2019 Feb; 30(5):747-761. PubMed ID: 28990403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging methods in therapeutics using multifunctional nanoparticles.
    Habibi N; Quevedo DF; Gregory JV; Lahann J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1625. PubMed ID: 32196991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of nanoparticle drug-delivery systems used in preclinical studies.
    Sreeharsha N; Chitrapriya N; Jang YJ; Kenchappa V
    Ther Deliv; 2021 Apr; 12(4):325-336. PubMed ID: 33759568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in Therapeutic Implications of Inorganic Drug Delivery Nano-Platforms for Cancer.
    Naz S; Shamoon M; Wang R; Zhang L; Zhou J; Chen J
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanotechnology Assisted Chemotherapy for Targeted Cancer Treatment: Recent Advances and Clinical Perspectives.
    Lan HR; Wu ZQ; Zhang LH; Jin KT; Wang SB
    Curr Top Med Chem; 2020; 20(27):2442-2458. PubMed ID: 32703133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances.
    Miller-Kleinhenz JM; Bozeman EN; Yang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(6):797-816. PubMed ID: 25966677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanobiotechnology-based drug delivery in brain targeting.
    Dinda SC; Pattnaik G
    Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanotechnologies for noninvasive measurement of drug release.
    Moore T; Chen H; Morrison R; Wang F; Anker JN; Alexis F
    Mol Pharm; 2014 Jan; 11(1):24-39. PubMed ID: 24215280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoparticle enhanced optical imaging and phototherapy of cancer.
    Pekkanen AM; DeWitt MR; Rylander MN
    J Biomed Nanotechnol; 2014 Sep; 10(9):1677-712. PubMed ID: 25992437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbon nanostructures as multi-functional drug delivery platforms.
    Mendes RG; Bachmatiuk A; Büchner B; Cuniberti G; Rümmeli MH
    J Mater Chem B; 2013 Jan; 1(4):401-428. PubMed ID: 32260810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanotechnology-based inhalation treatments for lung cancer: state of the art.
    Ahmad J; Akhter S; Rizwanullah M; Amin S; Rahman M; Ahmad MZ; Rizvi MA; Kamal MA; Ahmad FJ
    Nanotechnol Sci Appl; 2015; 8():55-66. PubMed ID: 26640374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macromolecular Drug Carriers for Targeted Glioblastoma Therapy: Preclinical Studies, Challenges, and Future Perspectives.
    Raucher D; Dragojevic S; Ryu J
    Front Oncol; 2018; 8():624. PubMed ID: 30619758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.